These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32037532)

  • 21. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
    Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
    J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    Rodriguez NM; Brennan LP; Claure L; Balian LN; Champion VL; Forman MR
    PLoS One; 2023; 18(3):e0282853. PubMed ID: 36893182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
    Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
    Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
    Devotta K; Vahabi M; Prakash V; Lofters A
    BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women.
    Winer RL; Gonzales AA; Noonan CJ; Cherne SL; Buchwald DS;
    J Community Health; 2016 Oct; 41(5):1049-61. PubMed ID: 27048284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba.
    Jalili F; O'Conaill C; Templeton K; Lotocki R; Fischer G; Manning L; Cormier K; Decker K
    Curr Oncol; 2019 Jun; 26(3):167-172. PubMed ID: 31285661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.
    Dzuba IG; Díaz EY; Allen B; Leonard YF; Lazcano Ponce EC; Shah KV; Bishai D; Lorincz A; Ferris D; Turnbull B; Hernández Avila M; Salmerón J
    J Womens Health Gend Based Med; 2002 Apr; 11(3):265-75. PubMed ID: 11988136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
    Liebermann E; Fontenot HB; Lim E; Matsunaga M; Zimet G; Allen JD
    J Obstet Gynecol Neonatal Nurs; 2023 Sep; 52(5):364-373. PubMed ID: 37355248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
    Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
    Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
    Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
    Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
    Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
    BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Bergengren L; Kaliff M; Larsson GL; Karlsson MG; Helenius G
    Int J Gynaecol Obstet; 2018 Sep; 142(3):359-364. PubMed ID: 29856071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding Patients' Perspectives and Information Needs Following a Positive Home Human Papillomavirus Self-Sampling Kit Result.
    Tiro JA; Betts AC; Kimbel K; Buist DSM; Mao C; Gao H; Shulman L; Malone C; Beatty T; Lin J; Thayer C; Miglioretti DL; Winer RL
    J Womens Health (Larchmt); 2019 Mar; 28(3):384-392. PubMed ID: 30481121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
    Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
    Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model.
    Dutton T; Marjoram J; Burgess S; Montgomery L; Vail A; Callan N; Jacob S; Hawkes D; Saville M; Bailey J
    BMC Health Serv Res; 2020 May; 20(1):398. PubMed ID: 32393243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tailored within-community specimen collection strategy increased uptake of cervical cancer screening in a cross-sectional study in Ghana.
    Awua AK; Wiredu EK; Afari EA; Tijani AS; Djanmah G; Adanu RMK
    BMC Public Health; 2017 Aug; 18(1):80. PubMed ID: 28764756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.